Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 1, 2008, Pages 112.e1-112.e7

  Speer, Paul D ^a   Powers, Robert W ^a,b   Frank, Michael P ^b   Harger, Gail ^b   Markovic, Nina ^a,b   Roberts, James M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

arginine; asymmetric dimethylarginine; preeclampsia; pregnancy; small for gestational age

Indexed keywords

ARGININE; N(G),N(G) DIMETHYLARGININE;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE COURSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MATERNAL BLOOD; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT;

EID: 37349026911     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.05.052     Document Type: Article

References (25)

1. American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists: diagnosis and management of preeclampsia and eclampsia: ACOG practice bulletin no. 33, January 2002. Obstet Gynecol 99 (2002) 159-161
2. Roberts J.M. Objective evidence of endothelial dysfunction in preeclampsia. Am J Kidney Dis 33 (1999) 992-994
3. Kingdom J.C.P., and Kaufmann P. Oxygen and placental vascular development. Adv Exp Med Biol 474 (1999) 259-275
4. Sladek S.M., Magness R.R., and Conrad K.P. Nitric oxide and pregnancy. Am J Physiol 272 (1997) R441-R463
5. Khalil R.A., and Granger J.P. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283 (2002) R29-R45
6. Cooke J.P. Does ADMA cause endothelial dysfunction?. Arterioscler Thromb Vasc Biol 20 (2000) 2032-2037
7. Cooke J.P. Asymmetrical dimethylarginine: the Uber marker?. Circulation 109 (2004) 1813-1818
8. Fickling S.A., Williams D., Vallance P., Nussey S.S., and Whitley G.S. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 342 (1993) 242-243
9. Holden D.P., Fickling S.A., Whitley G.S., and Nussey S.S. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol 178 (1998) 551-556
10. Pettersson A., Hedner T., and Milsom I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand 77 (1998) 808-813
11. Savvidou M.D., Hingorani A.D., Tsikas D., Frolich J.C., Vallance P., and Nicolaides K.H. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361 (2003) 1511-1517
12. Teerlink T., Nijveldt R.J., de Jong S., and van Leeuwen P.A. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303 (2002) 131-137
13. Ellis J., Wennerholm U.B., Bengtsson A., et al. Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 80 (2001) 602-608
14. Achan V., Broadhead M., Malaki M., et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23 (2003) 1455-1459
15. Boger R.H., Bode-Boger S.M., Szuba A., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 (1998) 1842-1847
16. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
17. Cooke J.P. NO and angiogenesis. Atheroscler Suppl 4 (2003) 53-60
18. Fukumura D., Gohongi T., Kadambi A., et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98 (2001) 2604-2609
19. Papapetropoulos A., Garcia-Cardena G., Madri J.A., and Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100 (1997) 3131-3139
20. Smith C.L., Birdsey G.M., Anthony S., Arrigoni F.I., Leiper J.M., and Vallance P. Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype. Biochem Biophys Res Comm 308 (2003) 984-989
21. Hubel C.A. Oxidative stress and preeclampsia. Fetal Matern Med Rev 9 (1997) 73-101
22. Ito A., Tsao P.S., Adimoolam S., Kimoto M., Ogawa T., and Cooke J.P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99 (1999) 3092-3095
23. Hershkovitz R., Kingdom J.C., Geary M., and Rodeck C.H. Fetal cerebral blood flow redistribution in late gestation: identification of compromise in small fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 15 (2000) 209-212
24. Krzyzanowska K., Mittermayer F., Kopp H.P., Wolzt M., and Schernthaner G. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab 89 (2004) 6277-6281
25. Rytlewski K., Olszanecki R., Korbut R., and Zdebski Z. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest 35 (2005) 32-37